E-cigarette Ban in Brazil: Ignorance and Health Risks

Aug.16.2024
E-cigarette Ban in Brazil: Ignorance and Health Risks
Brazil e-cigarette devices banned due to Anvisa decision, with many citizens unaware of the regulation, according to Folhape study.

According to a recent research report released by the Brazilian media Folhape, e-cigarette devices have been banned in Brazil due to a decision by the National Health Surveillance Agency (Anvisa). However, the study found that many Brazilian citizens are still unclear about the regulations surrounding this issue.


A report has shown that 87.2% of respondents are aware of what e-cigarettes are, but only 54.9% know that they are illegal products. Additionally, 44.6% of people believe that e-cigarettes are fashionable, while 20.7% think using them is relaxing. At the same time, 60% of respondents believe that smoking e-cigarettes is harmful to health.


Among the respondents, 74.6% said they have never used any type of e-cigarette, while 19.4% said they have used at least once. Among the group who have tried e-cigarettes before, 2.8% said they use them regularly.


Regarding safety, 90.3% of respondents are aware that e-cigarettes may be related to the occurrence of cancer, 94.8% of respondents know that they contain toxic substances, and 94.3% of respondents believe that e-cigarettes may increase the risk of chronic diseases.


However, 74.5% of respondents believe that it is acceptable to use e-cigarettes in bars and restaurants with outdoor areas, with 16.6% of people also thinking that it is permissible to use e-cigarettes in enclosed spaces.


The main reason why e-cigarettes are banned in Brazil is because they contain nicotine, which can lead to dependency. According to research from the Clinical Hospital of the University of Sao Paulo in Brazil, traditional cigarettes contain 1mg of nicotine, while e-cigarettes can contain up to 57mg per milliliter. Additionally, the Brazilian Medical Association (AMB) points out that one e-cigarette is equivalent to 20 traditional cigarettes.


Experts also point out that e-cigarettes contain up to 2000 substances, most of which are of unknown origin. The colorful packaging and fruity flavors are believed to be very attractive to teenagers, who are the main consumers of e-cigarettes.


A study by University College London (UCL) and the University of Innsbruck in Austria found that e-cigarettes may damage DNA, potentially leading to cancer. As a result, Brazil's National Health Surveillance Agency (Anvisa) has banned the production, distribution, storage, and transportation of e-cigarettes. This measure reinforces regulations put in place since 2009 that prohibit the import, sale, and promotion of e-cigarettes.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Arizona e-cigarette shops ordered to pay $460,000 for selling tobacco and nicotine products to minors
Arizona e-cigarette shops ordered to pay $460,000 for selling tobacco and nicotine products to minors
Arizona Attorney General Kris Mayes announced Pro Source Supply LLC, Pro Source Vapes LLC, Pro Source CBD LLC, and owner Timothy Kell must pay $460,000 in restitution tied to a lawsuit filed last year alleging illegal sales of tobacco and nicotine products to underage buyers.
Jan.07 by 2FIRSTS.ai
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Group announced that net sales for October–December 2025 rose 15% year-on-year to SEK 1,052.2 million, or 19% in constant currency terms. The company recorded 28% volume growth in the nicotine pouch category during the quarter. The number of orders increased to 1.34 million, and active consumers rose to 630,000, marking the highest level in the company’s history. CEO Gavin O’Dowd said the company’s accelerating topline performance in the US and UK positions it for a strong 2026.
Market
Feb.22
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
A provision in France’s 2026 finance bill intended to regulate vaping products was abandoned after Sébastien Lecornu used Article 49.3 on January 20 to commit the government’s responsibility on the “revenue” section of the state budget.
Jan.21 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai